Robert W Simms, Robert Lafyatis. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal, Murine-Derived/therapeutic useB-Lymphocytes/immunologyHumansImmunosuppressive Agents/therapeutic useLymphocyte Depletion/methodsRituximabScleroderma, Systemic/drug therapyScleroderma, Systemic/immunology
Substances: See more » Antibodies, Monoclonal, Murine-DerivedImmunosuppressive AgentsRituximab
Year: 2009 PMID: 20032221 DOI: 10.1093/rheumatology/kep421
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580